A61K 31/02
Halogenated hydrocarbons
A61K31/02 (Halogenated hydrocarbons) appears on 438 US grants and 579 published applications in this corpus.
Search patents in A61K- Granted patents
- 438
- Published applications
- 579
- Assignees
- 320
- Inventors
- 1,078
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 6 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 8 | 0 |
| 1990 | 4 | 0 |
| 1991 | 11 | 0 |
| 1992 | 8 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 13 | 0 |
| 1996 | 5 | 0 |
| 1997 | 12 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 7 | 0 |
| 2001 | 10 | 2 |
| 2002 | 16 | 10 |
| 2003 | 2 | 18 |
| 2004 | 2 | 23 |
| 2005 | 6 | 12 |
| 2006 | 6 | 14 |
| 2007 | 2 | 14 |
| 2008 | 4 | 15 |
| 2009 | 7 | 9 |
| 2010 | 8 | 21 |
| 2011 | 5 | 15 |
| 2012 | 7 | 15 |
| 2013 | 11 | 19 |
| 2014 | 8 | 19 |
| 2015 | 12 | 16 |
| 2016 | 12 | 30 |
| 2017 | 17 | 36 |
| 2018 | 28 | 49 |
| 2019 | 32 | 31 |
| 2020 | 25 | 37 |
| 2021 | 13 | 38 |
| 2022 | 15 | 30 |
| 2023 | 19 | 35 |
| 2024 | 26 | 33 |
| 2025 | 13 | 23 |
| 2026 | 5 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and Cushing's syndrome8 Sep 2026US 12,728,103 B2
- Otological surgery under perfluorocarbon liquids12 May 2026US 12,622,812 B2Alcon Inc.
- Compositions and methods for reducing greenhouse gas14 Apr 2026US 12,599,153 B2Rumin8 Pty Ltd
- Ophthalmic compositions comprising F6H810 Mar 2026US 12,569,452 B2Novaliq GmbH
- Energetic cancer stem cells (E-CSCS): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy17 Feb 2026US 12,553,092 B2Lunella Biotech, Inc.
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- Bicyclic compounds as inactivators of oat and gaba-at10 Sep 2026US 2026/0265177 A1Northwestern University
- Inhibition of methane production in ruminants13 Aug 2026US 2026/0232745 A1Loam Bio Pty Ltd
- Necrosis inhibitor30 Jul 2026US 2026/0216141 A1Linkgevity Limited
- Fluticasone and vilanterol formulation and inhaler16 Jul 2026US 2026/0199231 A1Kindeva Drug Delivery L. P.
Most cited
By later US patents
- Dissolution of gas in a fluorocarbon liquid174US 4,927,623 AAlliance Pharmaceutical Corp. · 1990
- Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport166US 4,865,836 AFluoromed Pharmaceutical, Inc. · 1989
- Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders153US 4,378,797 AThomas Jefferson University · 1983
- Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use143US 4,987,154 AAlliance Pharmaceutical Corp. · 1991
- Emulsions of highly fluorinated organic compounds130US 5,171,755 AHemaGen/PFC · 1992